Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts ...

Autistic adults show reduced availability of a key glutamate receptor, mGlu5, across widespread brain regions.